Does APREMILAST Cause Neoplasm malignant? 343 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 343 reports of Neoplasm malignant have been filed in association with APREMILAST (Otezla). This represents 0.3% of all adverse event reports for APREMILAST.
343
Reports of Neoplasm malignant with APREMILAST
0.3%
of all APREMILAST reports
33
Deaths
55
Hospitalizations
How Dangerous Is Neoplasm malignant From APREMILAST?
Of the 343 reports, 33 (9.6%) resulted in death, 55 (16.0%) required hospitalization, and 12 (3.5%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APREMILAST. However, 343 reports have been filed with the FAERS database.
What Other Side Effects Does APREMILAST Cause?
Diarrhoea (23,752)
Nausea (21,352)
Psoriasis (19,255)
Headache (17,024)
Drug ineffective (14,121)
Abdominal discomfort (7,653)
Psoriatic arthropathy (7,035)
Vomiting (5,959)
Rash (5,883)
Pain (5,676)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which APREMILAST Alternatives Have Lower Neoplasm malignant Risk?
APREMILAST vs APREPITANT
APREMILAST vs APROTININ
APREMILAST vs ARANESP
APREMILAST vs ARAVA
APREMILAST vs AREDIA